The loss of AMPK activity [19,20,31]. The decrease in AMP levels, secondary to reduced/absent activity in otherwise constantly active gravitational muscle tissues, for instance the soleus muscle, leads soon after 124 h of unloading to inactive AMPK accumulation, increased ceramide concentration and p70S6K activation. These detrimental effects, which bring about increased protein synthesis, presumably of essential proteolysis regulators, partially relieved just after the administration of AICAR (an AMPK activator) [31]. Even so, AICAR did not blunt MAFbx/Atrogin-1 and MuRF-1 upregulation [31], suggesting that other pathways than phosphorylated p70S6K are involved. Certainly, protein levels of a significant target of p70S6K, the Insulin Receptor Substrate 1 (IRS-1), whose Ser-phosphorylation hampers IR signaling and Akt activation, are also drastically decreased after 24 h-unloading [31]. IRS-1 proteostasis seems to become below the control with the ubiquitin-ligase Cbl-b [228], which increases its activity throughout unloading. Though an early involvement of improved Cbl-b activity has nonetheless to become demonstrated, Cbl-b ablation totally counteracted unloading-induced FoxO3 and MAFbx/Atrogin-1 accumulation, muscle mass, and force loss in mice [228]. The early qualitative and quantitative disruption on the IR-signaling pathway apparently follows costamere components disruption, i.e., the lower in melusin protein levels [128] along with the loss of nNOS sarcolemmal activity [30], each of them getting detectable six h right after unloading. Melusin loss is just not apparently detrimental for the activity of a number of of its targets, among which Akt, ERK1/2 and FAK, as shown by melusin replacement together with dominant-negative type of these kinases [128]. Conversely, the redistribution of active/uncoupled nNOS molecules seems to become needed upstream FoxO3 nuclear translocation, because decreased nNOS expression, following mRNA interference, or in vivo pharmacological inhibition of its enzyme activity, blunted FoxO3 activation [30]. SNIPERs Storage & Stability Recent proof demonstrated the presence of a functional/spatial partnership between DGC and IR, that is lost through fasting (i.e., in a situation top to muscle atrophy) [129]. The possibility exists that exactly the same “signaling hub” is perturbed by unloading-induced dysfunctions, which include nNOS untethering from DGC, and IRS-1 degradation and/or Serphosphorylation occurring roughly simultaneously, and resulting in downstream FoxO3 nuclear translocation. Interestingly, plakoglobin transcripts appear to be upregulated already 1 d after unloading [68], suggesting a compensatory response to early costamere-IR deregulation. Simultaneously together with the loss of sarcolemmal nNOS activity, unloading impacts the integrin element of costamere. Melusin loss occurs early and just before the proof of atrophy, each in humans (8 d-bed rest) [128] and in rodents (6 h unloading) [128], major, via nevertheless undefined effectors, to atrogene upregulation independently from FoxO3 activation. The truth is, melusin replacement attenuated atrophy by indicates of complete downregulation of MAFbx/Atrogin-1 and partial PAK custom synthesis silencing of MuRF-1 and, without the need of affecting FoxO3 nuclear localization and upregulation, which, conversely, appeared paradoxically elevated [128]. Certainly, unloading muscle atrophy didn’t develop right after counteracting each melusin loss and nNOS-induced FoxO3 activation. Therefore, unloading-induced muscle atrophy benefits by the early, parallel and independent involvement of two master regulators: a single is FoxO.
http://cathepsin-s.com
Cathepsins